Clinical Trial Update: PathToScale: The PERSIST Trial [NA]

View source ↗

Summary

Georgetown University is conducting the PathToScale: The PERSIST Trial to evaluate oral pre-exposure prophylaxis (PrEP) and long-acting injectable cabotegravir …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir long-acting injectable (cabotegravir)

Snippet

Sponsor: Georgetown University | Conditions: Oral Pre-exposure Prophylaxis (PrEP), Long-acting Injectable Cabotegravir for PrEP | NA | Status: RECRUITING